Australia, March 31 -- ELEPHAS BIOSCIENCES Corp., owns the trademark (2595245) for 'ELEPHAS LIVE' till Aug. 21, 2035.
Status: protected:
Registered/protected
Classes: 5 [Diagnostic reagents for medical use; diagnostic reagents for medical imaging; reagents for diagnostic assays, namely cytokine and secretome profiling for medical purposes; reagents for handling and preservation of biological samples for medical use; hydrogels for medical purposes; medical-grade materials for stabilizing and preserving tissue samples.], 10 [Medical imaging instruments; microscopes for medical diagnostic use; optical coherence microscopes for medical diagnostic use; medical instruments used to microscopically image biological samples; medical imaging devices for cancer diagnosis and monitoring of cancer treatment; medical instruments used to cut and process tissue samples.] and 42 [Providing temporary use of non-downloadable software for interpreting the results of medical imaging; providing temporary use of non-downloadable software for interpreting the results of diagnostic assays, namely cytokine and secretome profiling assays; providing temporary use of non-downloadable software for use in interpreting results from multiple diagnostic sources to inform treatment options; providing temporary use of non-downloadable software for obtaining, uploading, and analyzing the results medical imaging and diagnostic assays.]
Type of Mark: Word
Date of Acceptance: Jan. 20
Registration Advertised: March 30
For further details contact S.C. David W. Staple Casimir Jones.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2595245.
Disclaimer: Curated by HT Syndication.
